BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marichal-cancino BA, Manrique-maldonado G, Altamirano-espinoza AH, Ruiz-salinas I, González-hernández A, Maassenvandenbrink A, Villalón CM. Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats. European Journal of Pharmacology 2013;721:168-77. [DOI: 10.1016/j.ejphar.2013.09.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Allende G, Chávez-Reyes J, Guerrero-Alba R, Vázquez-León P, Marichal-Cancino BA. Advances in Neurobiology and Pharmacology of GPR12. Front Pharmacol 2020;11:628. [PMID: 32457622 DOI: 10.3389/fphar.2020.00628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Marichal-Cancino BA, Fajardo-Valdez A, Ruiz-Contreras AE, Mendez-Díaz M, Prospero-García O. Advances in the Physiology of GPR55 in the Central Nervous System. Curr Neuropharmacol 2017;15:771-8. [PMID: 27488130 DOI: 10.2174/1570159X14666160729155441] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
3 Guerrero-Alba R, Barragán-Iglesias P, González-Hernández A, Valdez-Moráles EE, Granados-Soto V, Condés-Lara M, Rodríguez MG, Marichal-Cancino BA. Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55. Front Pharmacol 2018;9:1496. [PMID: 30670965 DOI: 10.3389/fphar.2018.01496] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
4 Walsh SK, Lipina C, Ang SY, Sato M, Chia LY, Kocan M, Hutchinson DS, Summers RJ, Wainwright CL. GPR55 regulates the responsiveness to, but does not dimerise with, α1A-adrenoceptors. Biochem Pharmacol 2021;188:114560. [PMID: 33844984 DOI: 10.1016/j.bcp.2021.114560] [Reference Citation Analysis]
5 Ho WSV, Kelly MEM. Cannabinoids in the Cardiovascular System. Adv Pharmacol 2017;80:329-66. [PMID: 28826540 DOI: 10.1016/bs.apha.2017.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
6 Sánchez-Fuentes A, Marichal-Cancino BA, Méndez-Díaz M, Becerril-Meléndez AL, Ruiz-Contreras AE, Prospéro-Garcia O. mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system. Neurosci Lett 2016;631:104-8. [PMID: 27542344 DOI: 10.1016/j.neulet.2016.08.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
7 Hassan Almalki W, Alzahrani A, Mahmoud El-Daly ME, Faissal Fadel Ahmed AH. A molecular explanation of cardiovascular protection through abnormal cannabidiol: Involving the dysfunctional β-adrenergic and ATP-sensitive K+ channel activity in cardiovascular compromised preterm infants. J Biochem Mol Toxicol 2021;:e22849. [PMID: 34309957 DOI: 10.1002/jbt.22849] [Reference Citation Analysis]
8 Marichal-Cancino BA, Sánchez-Fuentes A, Méndez-Díaz M, Ruiz-Contreras AE, Prospéro-García O. Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm. Behav Pharmacol 2016;27:393-6. [PMID: 26292188 DOI: 10.1097/FBP.0000000000000185] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
9 Vázquez-León P, Miranda-Páez A, Chávez-Reyes J, Allende G, Barragán-Iglesias P, Marichal-Cancino BA. The Periaqueductal Gray and Its Extended Participation in Drug Addiction Phenomena. Neurosci Bull 2021. [PMID: 34302618 DOI: 10.1007/s12264-021-00756-y] [Reference Citation Analysis]
10 Ramírez-Orozco RE, García-Ruiz R, Morales P, Villalón CM, Villafán-Bernal JR, Marichal-Cancino BA. Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding. Curr Neuropharmacol 2019;17:947-60. [PMID: 31146657 DOI: 10.2174/1570159X17666190118143014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Karpińska O, Baranowska-Kuczko M, Malinowska B, Kloza M, Kusaczuk M, Gęgotek A, Golec P, Kasacka I, Kozłowska H. Mechanisms of l-alpha-lysophosphatidylinositol-induced relaxation in human pulmonary arteries. Life Sci 2018;192:38-45. [PMID: 29155298 DOI: 10.1016/j.lfs.2017.11.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
12 Willis MS, Ilaiwy A, Montgomery MD, Simpson PC, Jensen BC. The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo. Metabolomics 2016;12:155. [PMID: 28533737 DOI: 10.1007/s11306-016-1097-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Petrowski K, Kirschbaum C, Gao W, Hardt J, Conrad R. Blood endocannabinoid levels in patients with panic disorder. Psychoneuroendocrinology 2020;122:104905. [PMID: 33091759 DOI: 10.1016/j.psyneuen.2020.104905] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Garza-Cervantes JA, Ramos-González M, Lozano O, Jerjes-Sánchez C, García-Rivas G. Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure. Oxid Med Cell Longev 2020;2020:4587024. [PMID: 33194003 DOI: 10.1155/2020/4587024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Hassan Almalki W. A study of abnormal cannabidiols system-mediated cardiovascular protection in disrupted gut/brain axis associated depression. J Biochem Mol Toxicol 2021;35:e22930. [PMID: 34676637 DOI: 10.1002/jbt.22930] [Reference Citation Analysis]
16 Alhouayek M, Masquelier J, Muccioli GG. Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands. Trends Pharmacol Sci 2018;39:586-604. [PMID: 29588059 DOI: 10.1016/j.tips.2018.02.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
17 Marichal-Cancino BA, González-Hernández A, Muñoz-Islas E, Villalón CM. Monoaminergic Receptors as Modulators of the Perivascular Sympathetic and Sensory CGRPergic Outflows. Curr Neuropharmacol 2020;18:790-808. [PMID: 32364079 DOI: 10.2174/1570159X18666200503223240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]